KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
2015-12-30
Total Revenue
3,717
1,966
-
-
0
Cost of Revenue
585
324
-
-
0
Gross Profit
3,132
1,642
-
-
0
Operating Expenses
Research Development
29,119
26,399
17,665
13,861
19,412
Selling General and Administrative
34,793
26,499
13,988
8,308
7,850
Total Operating Expenses
63,912
52,898
31,653
22,169
27,262
Operating Income or Loss
-60,780
-51,256
-31,653
-22,169
-27,262
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
-655
0
Income Before Tax
-58,840
-49,690
-30,879
-22,499
-27,130
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-58,840
-49,690
-30,879
-22,499
-27,130
Net Income
-58,840
-49,690
-30,879
-22,499
-27,130
Net Income available to common shareholders
-58,840
-49,690
-30,879
-22,499
-27,130
Reported EPS
Basic
-
-1.60
-1.23
-1.13
-1.37
Diluted
-
-1.60
-1.23
-1.13
-1.37
Weighted average shares outstanding
Basic
-
31,001
25,084
19,873
19,773
Diluted
-
31,001
25,084
19,873
19,773
EBITDA
-
-50,451
-31,178
-22,014
-27,116